- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05221554
Pre-Op THA-modellering
Modellering van preoperatieve totale heupartroplastiek: geïndividualiseerde zorg, betere resultaten
Replacing diseased hip joints with prosthetic implants in a procedure called total hip arthroplasty (THA) is associated with high rates of patient satisfaction, pain relief, and functional improvement when the implant is appropriately placed. Incorrect implant size or placement may lead to a breadth of negative outcomes, which could result in the need for implant revision. It is difficult to assess the precise orientation of patient hips on the operating table, with one study revealing that only 26% of acetabular cups placed without technological assistance are correctly positioned. Using computer navigation as a guide to achieve optimal implant alignment may improve successful placement rates. The additional incorporation of real-time modeling software may further help realize higher rates of successful implant placement. This study, therefore, aims to investigate a computer navigation system coupled with real-time modeling software to establish the benefit of such technology in the operating room, and further improve positive patient outcomes following THA. We hypothesize that including technological assistance in THAs will yield better patient outcomes compared to surgeries performed freehand.
Studie Overzicht
Toestand
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Lyndsay Somerville
- Telefoonnummer: 36645 519-685-8500
- E-mail: Lyndsay.Somerville@lhsc.on.ca
Studie Contact Back-up
- Naam: Brent Lanting
- Telefoonnummer: 519-663-3335
- E-mail: Brent.Lanting@lhsc.on.ca
Studie Locaties
-
-
Ontario
-
London, Ontario, Canada, N6A5A5
- Werving
- London Health Sciences Centre
-
Contact:
- Lyndsay Somerville, PhD
- E-mail: lyndsay.somerville@lhsc.on.ca
-
Hoofdonderzoeker:
- Brent Lanting
-
Contact:
- Krysten Virag
- Telefoonnummer: 32789 519-685-8500
- E-mail: krysten.virag@lhsc.on.ca
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- osteoarthritis of the hip requiring primary THA
- 40 years of age or older
- BMI <40 kg/m2
- able to undergo CT
- able to provide informed consent, able and willing to do study assessments and follow instructions
Exclusion Criteria:
- prior surgery on the indicated hip with insertion of hardware
- prior surgery on the lower spine with insertion of hardware
- hip and/or spinal fixed deformities or inflammatory/ossification processes of the spine (e.g. DISH, ankylosing spondylolisthesis)
- diagnosis of inflammatory arthroplasty
- limitations to range of motion of the contralateral hip
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Prospective Imageless Computer-Navigated Cohort
Patients in this arm will receive standard patient of care implants but imageless navigation software will be used to plan optimal acetabular cup placement. |
Navigation software coupled with real-time modeling software will be used to plan optimal acetabular cup for patients undergoing THA. |
|
Actieve vergelijker: Cross-sectional Standard of Care Cohort
Patients in this arm will receive standard of care implants and undergo standard of care procedure for total hip arthroplasty. |
Patients already underwent THA procedure with manual placement of acetabular cup with conventional instrumentation. |
|
Experimenteel: Prospective CT-based Computer-Navigated Cohort
Patients in this arm will receive standard patient of care implants but computer navigation software will be used to plan optimal acetabular cup placement. |
CT- based computer navigation software coupled with modeling software will be used to plan optimal acetabular cup for patients undergoing THA. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Acetabular cup position
Tijdsspanne: 6 months post-op
|
CT examination. Measuring acetabular cup inclination and anteversion in degrees. |
6 months post-op
|
|
Protrusion length
Tijdsspanne: 6 months post-op
|
CT examination. Length of protrusion in the sagittal and axial view. |
6 months post-op
|
|
Acetabular cup loosening
Tijdsspanne: 6 months post-op
|
CT examination. Presence od acetabular cup loosening, indicated by periprosthetic radiolucency > 2 mm in width. |
6 months post-op
|
|
Degree of heterotopic ossification
Tijdsspanne: 6 months post-op
|
CT examination. Classification of heterotopic ossification based on Brooker Classification. |
6 months post-op
|
|
Muscle area
Tijdsspanne: 6 months post-op
|
CT examination measuring muscle cross-sectional area (in mm2). |
6 months post-op
|
|
Muscle density
Tijdsspanne: 6 months post-op
|
CT examination measuring radiological density (in HU). |
6 months post-op
|
|
Capsular scarring
Tijdsspanne: 6 months post-op
|
MRI examination. Measuring the joint capsule in its thickest part. |
6 months post-op
|
|
Joint effusion.
Tijdsspanne: 6 months post-op
|
MRI examination. Grading according to Mitchel et al. 1986 |
6 months post-op
|
|
Quantification of fluid.
Tijdsspanne: 6 months post-op
|
MRI examination. Grading according to Mitchel et al. 1986 |
6 months post-op
|
|
Heterotopic ossification in periarticular soft tissues.
Tijdsspanne: 6 months post-op
|
MRI examination. Classification of heterotopic ossification based on Brooker Classification. |
6 months post-op
|
|
Soft tissue impingement
Tijdsspanne: 6 months post-op
|
MRI examination. Measuring acetabular angle of anteversion. |
6 months post-op
|
|
Integrity of the periarticular muscles.
Tijdsspanne: 6 months post-op
|
MRI examination. Grading based on the Goutallier classification. |
6 months post-op
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Oxford Hip Score
Tijdsspanne: 3- and 6-months post-op
|
Joint-specific patient-reported outcome measure of disability in patients following THA |
3- and 6-months post-op
|
|
UCLA Activity Score
Tijdsspanne: 3- and 6-months post-op
|
Validated 10-point scale evaluating patient activity levels |
3- and 6-months post-op
|
|
VR-12
Tijdsspanne: 3- and 6-months post-op
|
Patient-reported outcome measure of patient's overall perspective of their health |
3- and 6-months post-op
|
|
WOMAC questionnaire
Tijdsspanne: 3- and 6-months post-op
|
Self-administered questionnaire assessing activities of daily living, functional mobility, gait, general health and quality of life. |
3- and 6-months post-op
|
|
Novel questionnaire
Tijdsspanne: 3- and 6-months post-op
|
Self-reported outcome measure that assess the patient's ability to perform 10 common activities of daily living (gait, pivot left, pivot right, upstairs, downstairs, step over, chair sit/rise, bend forward, sit low, and squat) |
3- and 6-months post-op
|
|
Harris Hip Score
Tijdsspanne: 3- and 6-months post-op
|
A measure of dysfunction following total hip arthroplasty |
3- and 6-months post-op
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Brent Lanting, London Health Sciences Centre/Lawson
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 11307
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .